Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-18-005804

Options or other derivatives

  • EVP, Chief Financial Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Bell Graeme EVP, Chief Financial Officer 2018-01-25 Grant or award · Stock Option (right to buy) +25,000 25,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…